The Chemours Co (NYSE:CC)

$ 28.96 0.5 (1.76%) Market Cap: 4.31 Bil Enterprise Value: 7.79 Bil PE Ratio: 0 PB Ratio: 5.68 GF Score: 78/100

Q1 2024 Chemours Co Earnings Call Transcript
May 01, 2024

$26 (-2.80%)

Earnings
Q4 2023 Chemours Co Earnings Call Transcript
Mar 28, 2024

$26.26 (-9.07%)

Earnings
Q3 2023 Chemours Co Earnings Call Transcript
Oct 27, 2023

$23.58 (-2.72%)

Earnings
Q2 2023 Chemours Co Earnings Call Transcript
Jul 28, 2023

$36.57 (-3.64%)

Earnings
Q1 2023 Chemours Co Earnings Call Transcript
Apr 28, 2023

$29.07 (+4.01%)

Earnings
Q4 2022 Chemours Co Earnings Call Transcript
Feb 10, 2023

$34.35 (+2.54%)

Earnings
Q3 2022 Chemours Co Earnings Call Transcript
Oct 26, 2022

$29.22 (+0.59%)

Earnings
Q2 2022 Chemours Co Earnings Call Transcript
Jul 29, 2022

$35.59 (+1.98%)

Earnings
Chemours Co Thermal and Specialized Solutions Investor Webinar Transcript
May 16, 2022
Q1 2022 Chemours Co Earnings Call Transcript
May 03, 2022

$38.91 (+17.55%)

Earnings
Q4 2021 Chemours Co Earnings Call Transcript
Feb 11, 2022

$30 (-15.42%)

Earnings
Q3 2021 Chemours Co Earnings Call Transcript
Nov 05, 2021

$32.56 (+10.30%)

Earnings
Q2 2021 Chemours Co Earnings Call Transcript
Jul 30, 2021

$33.25 (+0.97%)

Earnings
Chemours Co Advanced Performance Materials Investor Webinar Transcript
Jun 28, 2021
Q1 2021 Chemours Co Earnings Call Transcript
May 04, 2021

$31.53 (+1.68%)

Earnings
Q4 2020 Chemours Co Earnings Call Transcript
Feb 12, 2021

$26.14 (-4.91%)

Earnings
Energy Fuels Inc Set To Enter Commercial Rare Earth Production In Q1-2021 Corporate Call Transcript
Dec 15, 2020
Q3 2020 Chemours Co Earnings Call Transcript
Nov 04, 2020

$21.33 (-1.98%)

Earnings
Q2 2020 Chemours Co Earnings Call Transcript
Jul 31, 2020

$18.53 (+2.94%)

Earnings
Q1 2020 Chemours Co Earnings Call Transcript
May 06, 2020

$12.32 (+1.15%)

Earnings
Chemours Co at Barclays Industrial Select Conference Transcript
Feb 19, 2020
Q4 2019 Chemours Co Earnings Call Transcript
Feb 14, 2020

$19.37 (+23.53%)

Earnings
Q3 2019 Chemours Co Earnings Call Transcript
Nov 05, 2019

$19.78 (+10.69%)

Earnings
Q2 2019 Chemours Co Earnings Call Transcript
Aug 02, 2019

$14.69 (-19.11%)

Earnings
Q1 2019 Chemours Co Earnings Call Transcript
May 03, 2019

$34.18 (+0.03%)

Earnings
Q4 2018 Chemours Co Earnings Call Transcript
Feb 15, 2019

$37.75 (-2.43%)

Earnings

Q1 2023 Chemours Co Earnings Call Transcript

Apr 28, 2023 / 12:00PM GMT

Release Date Price: $29.07 (+4.01%)

Transcript 10-Q8-K

Operator

Good morning, and welcome to the Chemours Company First Quarter 2023 Earnings Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the call over to Jonathan Lock, SVP and Chief Development Officer. Thank you. Please go ahead.

Jonathan S. Lock

The Chemours Company - Section 16 Officer, Senior VP & Chief Development Officer

Thanks, Julianne, and good morning, everybody. Welcome to the Chemours Company's First Quarter 2023 Earnings Q&A Conference Call. I'm joined today by Mark Newman, President and Chief Executive Officer; and Sameer Ralhan, Senior Vice President and Chief Financial Officer.

Before we start, I'd like to remind you that comments made on this call as well as in the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties as described in our SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.